63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

26 trials found

diseases per page:

Showing 1 to 10 of 26 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05325593 (ClinicalTrials.gov)	December 2, 2022	7/3/2022	Romiplostim Plus Dexamethasonevs Dexamethasonein Patients With Newly Diagnosed Primary Immune Thromb ...	A Multicentre, Randomized, Open-label Study of Romiplostim Plus Dexamethasonevs Dexamethasonein Pati ...	Primary Immune Thrombocytopenia	Drug: romiplostim plus dexamethasone;Drug: Dexamethasone	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	NULL	Recruiting	18 Years	N/A	All	126	Phase 3	Spain
2	NCT04812483 (ClinicalTrials.gov)	September 1, 2022	1/3/2021	Immunomodulation With Eltrombopag in ITP	Immunomodulation in Young and Midlife Adults With Newly Diagnosed Primary Immune Thrombocytopenia (I ...	Primary Immune Thrombocytopenia (ITP)	Drug: Eltrombopag (Revolade®);Drug: standard therapy (without eltrombopag): HD-DXM	University Children's Hospital Basel	Stiftung zur Förderung medizinischer und biologischer Forschung;Novartis Pharmaceuticals;University ...	Recruiting	18 Years	55 Years	All	24	Phase 2	Switzerland
3	ChiCTR2100053604	2022-01-01	2021-11-24	A clinical study of the efficacy of low-dose prednisone maintenance therapy on adult patients with r ...	A clinical study of the efficacy of low-dose prednisone maintenance therapy on adult patients with r ...	Primary immune thrombocytopenia	Experimental group:High-dose dexamethasonefollowed by low-dose prednisonemaintenance treatment;Contr ...	The Second Affiliated Hospital of Guangxi Medical University	NULL	Recruiting	18	60	Both	Experimental group:113;Control group:113;	Phase 4	China
4	NCT03692754 (ClinicalTrials.gov)	November 1, 2021	29/9/2018	Atorvastatin in Management of Newly Diagnosed ITP	A Single-center Prospective Randomized Study of Atorvastatin in the Treatment of Newly Diagnosed Pri ...	Immune Thrombocytopenia;Purpura, Thrombocytopenic	Drug: Atorvastatin 20mg;Drug: Atorvastatin 10mg;Drug: Dexamethasone	Shandong University	NULL	Not yet recruiting	18 Years	80 Years	All	30	Phase 2/Phase 3	China
5	NCT05023915 (ClinicalTrials.gov)	August 21, 2021	21/8/2021	A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus ...	High-dose DexamethasonePlus Diammonium Glycyrrhizinate Enteric-coated Capsule Versus High-dose Dexam ...	Immune Thrombocytopenia	Drug: dexamethasone;Drug: diammonium glycyrrhizinate enteric-coated capsule	Shandong University	NULL	Recruiting	18 Years	80 Years	All	106	Phase 2	China
6	ChiCTR2100045747	2020-12-01	2021-04-23	Efficacy and safety study of corticosteroids plus hydroxychloroquine in first-line treatment of pati ...	Efficacy and safety study of corticosteroids plus hydroxychloroquine in first-line treatment of pati ...	primary immune thrombocytopenia	Experimental group:hydroxychloroquine + Dexamethasone;Control group:Dexamethasone;	Jinshan Hospital, Fudan University	NULL	Recruiting	18		Both	Experimental group:51;Control group:51;	Phase 4	China
7	ChiCTR2000035408	2020-08-20	2020-08-10	A randomized controlled study for rituximab in first-line treatment of newly diagnosed immune thromb ...	Study of rituximab in first-line treatment of newly diagnosed immune thrombocytopenia	Idiopathic Thrombocytopenic Purpura	Standard dose group:Rituximab(Hanrikang) 375mg/m2, 4 times a week (day 8, 15, 22, 29).;Low-dose grou ...	Henan Cancer Hospital	NULL	Recruiting	18	65	Both	Standard dose group:20;Low-dose group:20;Dexamethasone control group:20;	Phase 4	China
8	ChiCTR1900027735	2020-01-01	2019-11-24	Clinical study for high-dose dexamethasonecombined with versus without human recombinant thrombopoie ...	Clinical study for high-dose dexamethasonecombined with versus without human recombinant thrombopoie ...	Adult newly diagnosed immune thrombocytopenia	Study group:Dexamethasone40mg/d×4d, recombinant human thrombopoietin(rhTPO) 300U/Kg subcutaneous inj ...	Department of Hematology, Anhui Provincial Hospital	NULL	Pending	18	80	Both	Study group:30;Control group:30;	Phase 4	China
9	JPRN-jRCTs041190069	01/10/2019	25/09/2019	Clinical study to evaluate the efficacy of dexamethasonePalmitate for idiopathic (immune) thrombocyt ...	Clinical Investigation to evaluate the efficacy of dexamethasonepalmitate for idiopathic (immune) th ...	Chronic Idiopathic Thrombocytopenic Purpura refractory, immune, thrombocytopenia,;D016553	Administration of dexamethasone palmitate (5mg/day for 4 days)	Nakayama Takayuki	NULL	Recruiting	>= 20age old	<= 75age old	Both	7	Phase 1	Japan
10	NCT03998982 (ClinicalTrials.gov)	June 25, 2019	25/6/2019	Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP	A Single-center Prospective Randomized Study of Glycyrrhetinic Acid Combined With Dexamethasonein th ...	Immune Thrombocytopenia	Drug: Glycyrrhetinic Acid;Drug: Dexamethasone	Shandong University	NULL	Recruiting	18 Years	80 Years	All	30	Phase 4	China

First Previous1 2 3Next Last